SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001016169-11-000006
Filing Date
2011-04-15
Accepted
2011-04-15 14:14:40
Documents
4
Period of Report
2011-05-17
Effectiveness Date
2011-04-15

Document Format Files

Seq Description Document Type Size
1 proxy.htm DEF 14A 1036849
2 paulw.jpg GRAPHIC 3010
3 bob.jpg GRAPHIC 2075
4 logojune2010.jpg GRAPHIC 6950
  Complete submission text file 0001016169-11-000006.txt   1055126
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 11762035
SIC: 3841 Surgical & Medical Instruments & Apparatus